HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-SEP-18 6MHD TITLE GLUTATHIONE S-TRANSFERASE OMEGA 1 BOUND TO COVALENT INHIBITOR 44 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE OMEGA-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSTO-1,GLUTATHIONE S-TRANSFERASE OMEGA 1-1,GSTO 1-1, COMPND 5 GLUTATHIONE-DEPENDENT DEHYDROASCORBATE REDUCTASE,MONOMETHYLARSONIC COMPND 6 ACID REDUCTASE,MMA(V) REDUCTASE,S-(PHENACYL)GLUTATHIONE REDUCTASE, COMPND 7 SPG-R; COMPND 8 EC: 2.5.1.18,1.8.5.1,1.20.4.2; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTO1, GSTTLP28; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, TRANSFERASE INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.M.PETRUNAK,J.A.STUCKEY REVDAT 3 11-OCT-23 6MHD 1 REMARK REVDAT 2 10-APR-19 6MHD 1 JRNL REVDAT 1 20-FEB-19 6MHD 0 JRNL AUTH W.DAI,S.SAMANTA,D.XUE,E.M.PETRUNAK,J.A.STUCKEY,Y.HAN,D.SUN, JRNL AUTH 2 Y.WU,N.NEAMATI JRNL TITL STRUCTURE-BASED DESIGN OF JRNL TITL 2 N-(5-PHENYLTHIAZOL-2-YL)ACRYLAMIDES AS NOVEL AND POTENT JRNL TITL 3 GLUTATHIONE S-TRANSFERASE OMEGA 1 INHIBITORS. JRNL REF J. MED. CHEM. V. 62 3068 2019 JRNL REFN ISSN 1520-4804 JRNL PMID 30735370 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01960 REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.1 REMARK 3 NUMBER OF REFLECTIONS : 22325 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1109 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 51.31 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 447 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2056 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 424 REMARK 3 BIN R VALUE (WORKING SET) : 0.2031 REMARK 3 BIN FREE R VALUE : 0.2518 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.15 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3741 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 149 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.54 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.81390 REMARK 3 B22 (A**2) : 1.58390 REMARK 3 B33 (A**2) : -0.76990 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.34200 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.336 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.223 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.346 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.226 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.886 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3991 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5492 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1306 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 703 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3991 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 500 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4749 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.04 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.27 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MHD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-SEP-18. REMARK 100 THE DEPOSITION ID IS D_1000236957. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1272 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22575 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.2 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08600 REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.33500 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4YQU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 6.5, 30% PEG-3350, 4% REMARK 280 ACETONE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.53000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A -1 CG OD1 ND2 REMARK 470 MET A 1 SD CE REMARK 470 SER A 5 OG REMARK 470 LYS A 11 CD CE NZ REMARK 470 GLU A 21 CG CD OE1 OE2 REMARK 470 LYS A 43 CE NZ REMARK 470 GLU A 61 CG CD OE1 OE2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 LYS A 101 CG CD CE NZ REMARK 470 LYS A 122 CD CE NZ REMARK 470 GLN A 134 CG CD OE1 NE2 REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 GLU A 137 CG CD OE1 OE2 REMARK 470 GLU A 144 CG CD OE1 OE2 REMARK 470 LYS A 148 CG CD CE NZ REMARK 470 LYS A 160 CG CD CE NZ REMARK 470 LYS A 161 CG CD CE NZ REMARK 470 LYS A 188 CG CD CE NZ REMARK 470 LYS A 198 CE NZ REMARK 470 GLU A 208 CG CD OE1 OE2 REMARK 470 GLU B 21 CG CD OE1 OE2 REMARK 470 LYS B 43 CE NZ REMARK 470 ARG B 48 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 50 CG CD OE1 OE2 REMARK 470 LYS B 65 CG CD CE NZ REMARK 470 GLU B 85 CG CD OE1 OE2 REMARK 470 GLU B 95 CG CD OE1 OE2 REMARK 470 LYS B 101 CD CE NZ REMARK 470 LYS B 110 CG CD CE NZ REMARK 470 LYS B 122 CG CD CE NZ REMARK 470 GLN B 134 CG CD OE1 NE2 REMARK 470 ASN B 135 CG OD1 ND2 REMARK 470 LYS B 136 CG CD CE NZ REMARK 470 GLU B 137 CG CD OE1 OE2 REMARK 470 ASP B 138 CG OD1 OD2 REMARK 470 LYS B 143 CE NZ REMARK 470 GLU B 144 CG CD OE1 OE2 REMARK 470 LYS B 148 CG CD CE NZ REMARK 470 LYS B 160 CG CD CE NZ REMARK 470 LYS B 161 CD CE NZ REMARK 470 ASN B 168 CG OD1 ND2 REMARK 470 GLU B 185 CG CD OE1 OE2 REMARK 470 LYS B 188 CG CD CE NZ REMARK 470 LYS B 198 CD CE NZ REMARK 470 LYS B 200 CG CD CE NZ REMARK 470 LEU B 201 CG CD1 CD2 REMARK 470 LYS B 207 CG CD CE NZ REMARK 470 LEU B 216 CG CD1 CD2 REMARK 470 GLN B 223 CG CD OE1 NE2 REMARK 470 GLU B 227 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 2 52.56 -144.98 REMARK 500 ASN A 58 54.30 -161.55 REMARK 500 GLU A 85 115.56 84.06 REMARK 500 SER B 2 61.64 -163.51 REMARK 500 ASN B 58 60.40 -165.57 REMARK 500 GLU B 85 123.21 80.42 REMARK 500 SER B 121 -27.92 -38.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JRD A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MES A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACN A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MES B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACN B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide JRD B 301 and CYS B REMARK 800 32 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6MHB RELATED DB: PDB REMARK 900 6MHB CONTAINS THE SAME PROTEIN BOUND TO STRUCTURALLY-SIMILAR REMARK 900 COVALENT INHIBITOR 18 REMARK 900 RELATED ID: 6MHC RELATED DB: PDB REMARK 900 6MHB CONTAINS THE SAME PROTEIN BOUND TO STRUCTURALLY-SIMILAR REMARK 900 COVALENT INHIBITOR 37 DBREF 6MHD A 1 241 UNP P78417 GSTO1_HUMAN 1 241 DBREF 6MHD B 1 241 UNP P78417 GSTO1_HUMAN 1 241 SEQADV 6MHD SER A -2 UNP P78417 EXPRESSION TAG SEQADV 6MHD ASN A -1 UNP P78417 EXPRESSION TAG SEQADV 6MHD ALA A 0 UNP P78417 EXPRESSION TAG SEQADV 6MHD SER B -2 UNP P78417 EXPRESSION TAG SEQADV 6MHD ASN B -1 UNP P78417 EXPRESSION TAG SEQADV 6MHD ALA B 0 UNP P78417 EXPRESSION TAG SEQRES 1 A 244 SER ASN ALA MET SER GLY GLU SER ALA ARG SER LEU GLY SEQRES 2 A 244 LYS GLY SER ALA PRO PRO GLY PRO VAL PRO GLU GLY SER SEQRES 3 A 244 ILE ARG ILE TYR SER MET ARG PHE CYS PRO PHE ALA GLU SEQRES 4 A 244 ARG THR ARG LEU VAL LEU LYS ALA LYS GLY ILE ARG HIS SEQRES 5 A 244 GLU VAL ILE ASN ILE ASN LEU LYS ASN LYS PRO GLU TRP SEQRES 6 A 244 PHE PHE LYS LYS ASN PRO PHE GLY LEU VAL PRO VAL LEU SEQRES 7 A 244 GLU ASN SER GLN GLY GLN LEU ILE TYR GLU SER ALA ILE SEQRES 8 A 244 THR CYS GLU TYR LEU ASP GLU ALA TYR PRO GLY LYS LYS SEQRES 9 A 244 LEU LEU PRO ASP ASP PRO TYR GLU LYS ALA CYS GLN LYS SEQRES 10 A 244 MET ILE LEU GLU LEU PHE SER LYS VAL PRO SER LEU VAL SEQRES 11 A 244 GLY SER PHE ILE ARG SER GLN ASN LYS GLU ASP TYR ALA SEQRES 12 A 244 GLY LEU LYS GLU GLU PHE ARG LYS GLU PHE THR LYS LEU SEQRES 13 A 244 GLU GLU VAL LEU THR ASN LYS LYS THR THR PHE PHE GLY SEQRES 14 A 244 GLY ASN SER ILE SER MET ILE ASP TYR LEU ILE TRP PRO SEQRES 15 A 244 TRP PHE GLU ARG LEU GLU ALA MET LYS LEU ASN GLU CYS SEQRES 16 A 244 VAL ASP HIS THR PRO LYS LEU LYS LEU TRP MET ALA ALA SEQRES 17 A 244 MET LYS GLU ASP PRO THR VAL SER ALA LEU LEU THR SER SEQRES 18 A 244 GLU LYS ASP TRP GLN GLY PHE LEU GLU LEU TYR LEU GLN SEQRES 19 A 244 ASN SER PRO GLU ALA CYS ASP TYR GLY LEU SEQRES 1 B 244 SER ASN ALA MET SER GLY GLU SER ALA ARG SER LEU GLY SEQRES 2 B 244 LYS GLY SER ALA PRO PRO GLY PRO VAL PRO GLU GLY SER SEQRES 3 B 244 ILE ARG ILE TYR SER MET ARG PHE CYS PRO PHE ALA GLU SEQRES 4 B 244 ARG THR ARG LEU VAL LEU LYS ALA LYS GLY ILE ARG HIS SEQRES 5 B 244 GLU VAL ILE ASN ILE ASN LEU LYS ASN LYS PRO GLU TRP SEQRES 6 B 244 PHE PHE LYS LYS ASN PRO PHE GLY LEU VAL PRO VAL LEU SEQRES 7 B 244 GLU ASN SER GLN GLY GLN LEU ILE TYR GLU SER ALA ILE SEQRES 8 B 244 THR CYS GLU TYR LEU ASP GLU ALA TYR PRO GLY LYS LYS SEQRES 9 B 244 LEU LEU PRO ASP ASP PRO TYR GLU LYS ALA CYS GLN LYS SEQRES 10 B 244 MET ILE LEU GLU LEU PHE SER LYS VAL PRO SER LEU VAL SEQRES 11 B 244 GLY SER PHE ILE ARG SER GLN ASN LYS GLU ASP TYR ALA SEQRES 12 B 244 GLY LEU LYS GLU GLU PHE ARG LYS GLU PHE THR LYS LEU SEQRES 13 B 244 GLU GLU VAL LEU THR ASN LYS LYS THR THR PHE PHE GLY SEQRES 14 B 244 GLY ASN SER ILE SER MET ILE ASP TYR LEU ILE TRP PRO SEQRES 15 B 244 TRP PHE GLU ARG LEU GLU ALA MET LYS LEU ASN GLU CYS SEQRES 16 B 244 VAL ASP HIS THR PRO LYS LEU LYS LEU TRP MET ALA ALA SEQRES 17 B 244 MET LYS GLU ASP PRO THR VAL SER ALA LEU LEU THR SER SEQRES 18 B 244 GLU LYS ASP TRP GLN GLY PHE LEU GLU LEU TYR LEU GLN SEQRES 19 B 244 ASN SER PRO GLU ALA CYS ASP TYR GLY LEU HET JRD A 401 39 HET MES A 402 25 HET ACN A 403 10 HET JRD B 301 39 HET MES B 302 25 HET ACN B 303 10 HETNAM JRD N-[(3-METHYL-1,2-OXAZOL-5-YL)METHYL]-N-(4-PHENYL-1,3- HETNAM 2 JRD THIAZOL-2-YL)PROPANAMIDE HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM ACN ACETONE FORMUL 3 JRD 2(C17 H17 N3 O2 S) FORMUL 4 MES 2(C6 H13 N O4 S) FORMUL 5 ACN 2(C3 H6 O) FORMUL 9 HOH *149(H2 O) HELIX 1 AA1 CYS A 32 LYS A 45 1 14 HELIX 2 AA2 PRO A 60 LYS A 66 5 7 HELIX 3 AA3 GLU A 85 TYR A 97 1 13 HELIX 4 AA4 ASP A 106 SER A 121 1 16 HELIX 5 AA5 SER A 121 ARG A 132 1 12 HELIX 6 AA6 ASN A 135 LYS A 161 1 27 HELIX 7 AA7 SER A 171 GLU A 182 1 12 HELIX 8 AA8 LEU A 189 ASP A 194 5 6 HELIX 9 AA9 THR A 196 ASP A 209 1 14 HELIX 10 AB1 ASP A 209 LEU A 215 1 7 HELIX 11 AB2 SER A 218 GLN A 231 1 14 HELIX 12 AB3 CYS B 32 LYS B 45 1 14 HELIX 13 AB4 PRO B 60 LYS B 66 5 7 HELIX 14 AB5 GLU B 85 TYR B 97 1 13 HELIX 15 AB6 ASP B 106 SER B 121 1 16 HELIX 16 AB7 SER B 121 SER B 133 1 13 HELIX 17 AB8 ASN B 135 LYS B 161 1 27 HELIX 18 AB9 SER B 171 GLU B 182 1 12 HELIX 19 AC1 LEU B 189 ASP B 194 5 6 HELIX 20 AC2 THR B 196 GLU B 208 1 13 HELIX 21 AC3 ASP B 209 LEU B 215 1 7 HELIX 22 AC4 SER B 218 GLN B 231 1 14 SHEET 1 AA1 4 HIS A 49 ASN A 53 0 SHEET 2 AA1 4 ILE A 24 SER A 28 1 N ILE A 26 O ILE A 52 SHEET 3 AA1 4 VAL A 74 ASN A 77 -1 O VAL A 74 N TYR A 27 SHEET 4 AA1 4 LEU A 82 TYR A 84 -1 O ILE A 83 N LEU A 75 SHEET 1 AA2 4 HIS B 49 ASN B 53 0 SHEET 2 AA2 4 ILE B 24 SER B 28 1 N ILE B 26 O ILE B 52 SHEET 3 AA2 4 VAL B 74 ASN B 77 -1 O GLU B 76 N ARG B 25 SHEET 4 AA2 4 LEU B 82 TYR B 84 -1 O ILE B 83 N LEU B 75 LINK SG CYS A 32 C2 JRD A 401 1555 1555 1.81 LINK SG CYS B 32 C2 JRD B 301 1555 1555 1.81 CISPEP 1 VAL A 72 PRO A 73 0 -1.46 CISPEP 2 VAL B 72 PRO B 73 0 4.36 SITE 1 AC1 11 MET A 29 CYS A 32 PHE A 34 LEU A 56 SITE 2 AC1 11 VAL A 72 GLY A 128 ILE A 131 ARG A 132 SITE 3 AC1 11 TYR A 229 ACN A 403 HOH A 583 SITE 1 AC2 6 PHE A 34 GLU A 85 SER A 86 HOH A 509 SITE 2 AC2 6 HOH A 530 GLU B 118 SITE 1 AC3 5 PRO A 33 VAL A 127 GLY A 128 TRP A 180 SITE 2 AC3 5 JRD A 401 SITE 1 AC4 6 GLU A 118 PHE B 34 LEU B 71 VAL B 72 SITE 2 AC4 6 GLU B 85 SER B 86 SITE 1 AC5 5 PRO B 33 PRO B 124 VAL B 127 TRP B 180 SITE 2 AC5 5 JRD B 301 SITE 1 AC6 14 MET B 29 ARG B 30 PHE B 31 PRO B 33 SITE 2 AC6 14 PHE B 34 ALA B 35 GLU B 36 LEU B 56 SITE 3 AC6 14 VAL B 72 GLY B 128 ILE B 131 TYR B 229 SITE 4 AC6 14 ACN B 303 HOH B 415 CRYST1 60.159 71.060 60.443 90.00 114.73 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016623 0.000000 0.007656 0.00000 SCALE2 0.000000 0.014073 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018215 0.00000